Loading…
Product type
Regorafenib is a targeted therapy medication used primarily in the treatment of various types of cancer, including colorectal cancer and gastrointestinal stromal tumors. It functions as a multi-kinase inhibitor, blocking several protein kinases involved in tumor growth and angiogenesis, which is the formation of new blood vessels that supply tumors. Regorafenib is typically administered orally in tablet form, allowing for convenient outpatient treatment.
| Chemical formula | C21H21ClF2N4O3 |
| Molecular weight | 454.87 g/mol |
| Purity | Typically ≥ 98% |
| Form | Powder or tablet |
| Storage conditions | Store in a cool, dry place, protected from light |
When selecting regorafenib as an active pharmaceutical ingredient, buyers should consider the required purity levels and any specific regulatory certifications needed for their region. It is also important to specify the desired form, whether as a powder or tablet, along with the necessary quantities for production. Buyers should inquire about stability data and storage conditions to ensure proper handling and efficacy of the product.
Get quotes for Regorafenib
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Regorafenib is used to treat certain types of cancer, including colorectal cancer and gastrointestinal stromal tumors.
Regorafenib is typically taken orally in tablet form.
Common side effects include fatigue, diarrhea, and skin reactions.
Regorafenib is a brand-name drug; however, generic versions may become available after patent expiration.
It should be stored in a cool, dry place, away from light to maintain its efficacy.
Yes, regorafenib can be used in combination with other cancer treatments, but this should be determined by a healthcare professional.